Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Bilprevda 120 mg Solution for injection {equilateral_black_triangle}

Active Ingredient:
denosumab
Company:  
Organon Pharma (UK) Limited See contact details
ATC code: 
M05BX04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Letters to HCPs
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Bilprevda Patient Reminder Card

This reminder card contains important safety information that patients need to be aware of before and during treatment with Bilprevda® (denosumab) injections for cancer-related conditions.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Organon Pharma (UK) Limited
Company image
Address
Shotton Lane, Cramlington, NE23 3JU, UK
Telephone
+44 (0) 208 159 3593
Medical Information e-mail
[email protected]
Customer Care direct line
+44 (0) 208 159 3500
WWW
https://www.organon.com/uk/
Adverse event reporting email
[email protected]